United Health Products Inc

For the period ended Dec 31, 2023. Filed Apr 1, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 1, 2024

UEECStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 9B. Other Information

Cash paid for amounts included in the measurement of lease liabilities for the year ended December 31, 2023		$19,950
Weighted average remaining lease term – operating leases (in years)	2.42 years
Average discount rate – operating lease		10%

The supplemental balance sheet information related to leases for the period is as follows:

At December31, 2023 · At December31, 2022
Operating leases
Remaining right-of-use assets	$76,520	$	-
Short-term operating lease liabilities	$28,838	$	-
Long-term operating lease liabilities	$48,489	$	-
Total operating lease liabilities	$77,327	$	-

Maturities of the Company’s undiscounted lease liabilities are as follows:

Year Ending	OperatingLeases
2024	$34,998
2025	36,394
2026	15,410
Total lease payments	86,802
Less: Imputed interest/present value discount	(9,475)
Present value of lease liabilities	$77,327

Note 12. Subsequent Events

The Company has evaluated events from December 31, 2023, through the date whereupon the financial statements were issued and has determined that there are no material events that need to be disclosed, except as follows:

The Company issued shares of common stock for the following:

·	2,050,000 shares of common stock were sold to White Lion and received net proceeds of $391,225 after administrative fees related to the CSPA of $3,600 were deducted.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.